Page last updated: 2024-09-05

ag 112 and 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione

ag 112 has been researched along with 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione in 1 studies

Compound Research Comparison

Studies
(ag 112)
Trials
(ag 112)
Recent Studies (post-2010)
(ag 112)
Studies
(2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione)
Trials
(2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione)
Recent Studies (post-2010) (2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione)
19010906

Protein Interaction Comparison

ProteinTaxonomyag 112 (IC50)2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.39
Cyclin-dependent kinase 4Homo sapiens (human)7.1667
G1/S-specific cyclin-D1Homo sapiens (human)7.75
N-lysine methyltransferase KMT5AHomo sapiens (human)0.435

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1

Other Studies

1 other study(ies) available for ag 112 and 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione

ArticleYear
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013